265 related articles for article (PubMed ID: 33328983)
1. Activation of the AMPK-SIRT1 pathway contributes to protective effects of Salvianolic acid A against lipotoxicity in hepatocytes and NAFLD in mice.
Li S; Qian Q; Ying N; Lai J; Feng L; Zheng S; Jiang F; Song Q; Chai H; Dou X
Front Pharmacol; 2020; 11():560905. PubMed ID: 33328983
[No Abstract] [Full Text] [Related]
2. Activation of AMP-Activated Protein Kinase-Sirtuin 1 Pathway Contributes to Salvianolic Acid A-Induced Browning of White Adipose Tissue in High-Fat Diet Fed Male Mice.
Lai J; Qian Q; Ding Q; Zhou L; Fu A; Du Z; Wang C; Song Z; Li S; Dou X
Front Pharmacol; 2021; 12():614406. PubMed ID: 34122060
[No Abstract] [Full Text] [Related]
3. Cimifugin Ameliorates Lipotoxicity-Induced Hepatocyte Damage and Steatosis through TLR4/p38 MAPK- and SIRT1-Involved Pathways.
Yang W; Zhu L; Lai S; Ding Q; Xu T; Guo R; Dou X; Chai H; Yu Z; Li S
Oxid Med Cell Longev; 2022; 2022():4557532. PubMed ID: 35355867
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of TLR4/MAPKs Pathway Contributes to the Protection of Salvianolic Acid A Against Lipotoxicity-Induced Myocardial Damage in Cardiomyocytes and Obese Mice.
Yang Z; Chen Y; Yan Z; Xu TT; Wu X; Pi A; Liu Q; Chai H; Li S; Dou X
Front Pharmacol; 2021; 12():627123. PubMed ID: 33762947
[TBL] [Abstract][Full Text] [Related]
5. Tetrahydropalmatine ameliorates hepatic steatosis in nonalcoholic fatty liver disease by switching lipid metabolism via AMPK-SREBP-1c-Sirt1 signaling axis.
Yin X; Liu Z; Wang J
Phytomedicine; 2023 Oct; 119():155005. PubMed ID: 37562090
[TBL] [Abstract][Full Text] [Related]
6. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease
Li CX; Gao JG; Wan XY; Chen Y; Xu CF; Feng ZM; Zeng H; Lin YM; Ma H; Xu P; Yu CH; Li YM
World J Gastroenterol; 2019 Sep; 25(34):5120-5133. PubMed ID: 31558861
[TBL] [Abstract][Full Text] [Related]
7. Atractylenolide III ameliorates Non-Alcoholic Fatty Liver Disease by activating Hepatic Adiponectin Receptor 1-Mediated AMPK Pathway.
Li Q; Tan JX; He Y; Bai F; Li SW; Hou YW; Ji LS; Gao YT; Zhang X; Zhou ZH; Yu Z; Fang M; Gao YQ; Li M
Int J Biol Sci; 2022; 18(4):1594-1611. PubMed ID: 35280674
[No Abstract] [Full Text] [Related]
8. tert-Butylhydroquinone (tBHQ) protects hepatocytes against lipotoxicity via inducing autophagy independently of Nrf2 activation.
Li S; Li J; Shen C; Zhang X; Sun S; Cho M; Sun C; Song Z
Biochim Biophys Acta; 2014 Jan; 1841(1):22-33. PubMed ID: 24055888
[TBL] [Abstract][Full Text] [Related]
9. Salvia-Nelumbinis naturalis improves lipid metabolism of NAFLD by regulating the SIRT1/AMPK signaling pathway.
Liu Y; Li Y; Wang J; Yang L; Yu X; Huang P; Song H; Zheng P
BMC Complement Med Ther; 2022 Aug; 22(1):213. PubMed ID: 35945571
[TBL] [Abstract][Full Text] [Related]
10. Protopanaxadiol ameliorates NAFLD by regulating hepatocyte lipid metabolism through AMPK/SIRT1 signaling pathway.
Li Y; Liu Y; Chen Z; Tang K; Yang L; Jiang Y; Wang J; Huang P; Wang J; Zheng P; Song H
Biomed Pharmacother; 2023 Apr; 160():114319. PubMed ID: 36724639
[TBL] [Abstract][Full Text] [Related]
11. Berberine Ameliorates Abnormal Lipid Metabolism via the Adenosine Monophosphate-Activated Protein Kinase/Sirtuin 1 Pathway in Alcohol-Related Liver Disease.
Zhu L; Xu JJ; Li HD; Li JJ; Cheng M; Niu XN; Jia PC; Liu JY; Huang C; Lv XW; Li J
Lab Invest; 2023 Apr; 103(4):100041. PubMed ID: 36870291
[TBL] [Abstract][Full Text] [Related]
12. Ferulic acid alleviates lipotoxicity-induced hepatocellular death through the SIRT1-regulated autophagy pathway and independently of AMPK and Akt in AML-12 hepatocytes.
Xu T; Song Q; Zhou L; Yang W; Wu X; Qian Q; Chai H; Han Q; Pan H; Dou X; Li S
Nutr Metab (Lond); 2021 Jan; 18(1):13. PubMed ID: 33468182
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of HMGB1 release via salvianolic acid B-mediated SIRT1 up-regulation protects rats against non-alcoholic fatty liver disease.
Zeng W; Shan W; Gao L; Gao D; Hu Y; Wang G; Zhang N; Li Z; Tian X; Xu W; Peng J; Ma X; Yao J
Sci Rep; 2015 Nov; 5():16013. PubMed ID: 26525891
[TBL] [Abstract][Full Text] [Related]
14. Cryptotanshinone from the
Nagappan A; Kim JH; Jung DY; Jung MH
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31906014
[TBL] [Abstract][Full Text] [Related]
15. Patchouli alcohol ameliorates skeletal muscle insulin resistance and NAFLD via AMPK/SIRT1-mediated suppression of inflammation.
Pyun DH; Kim TJ; Park SY; Lee HJ; Abd El-Aty AM; Jeong JH; Jung TW
Mol Cell Endocrinol; 2021 Dec; 538():111464. PubMed ID: 34601002
[TBL] [Abstract][Full Text] [Related]
16. LB100 ameliorates nonalcoholic fatty liver disease
Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
[TBL] [Abstract][Full Text] [Related]
17. Nicotinamide ameliorates palmitate-induced ER stress in hepatocytes via cAMP/PKA/CREB pathway-dependent Sirt1 upregulation.
Li J; Dou X; Li S; Zhang X; Zeng Y; Song Z
Biochim Biophys Acta; 2015 Nov; 1853(11 Pt A):2929-36. PubMed ID: 26352206
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacy of mitochondria-targeted esculetin in the improvement of NAFLD-NASH via modulating AMPK-SIRT1 axis.
Singuru G; Pulipaka S; Shaikh A; Balaji Andugulapati S; Thennati R; Kotamraju S
Int Immunopharmacol; 2023 Nov; 124(Pt B):111070. PubMed ID: 37862737
[TBL] [Abstract][Full Text] [Related]
19. Tangshen Formula Alleviates Hepatic Steatosis by Inducing Autophagy Through the AMPK/SIRT1 Pathway.
Wang Y; Zhao H; Li X; Li N; Wang Q; Liu Y; Liang Q; Shao Z; Zhang N; Zhao T; Peng L; Li P
Front Physiol; 2019; 10():494. PubMed ID: 31105592
[TBL] [Abstract][Full Text] [Related]
20. miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease.
Long JK; Dai W; Zheng YW; Zhao SP
Mol Med; 2019 Jun; 25(1):26. PubMed ID: 31195981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
